Vigmed Holding AB brings forward publication of the interim report.

The Board of Directors of Vigmed Holding AB (publ) has made a resolution to publish the interim report for January - September 2015 earlier than previously announced. The report will be published before trading starts on Tuesday October 27, 2015.

For further information contact:
Chairman of the board, Lennart Holm +46 70 630 8562 or
CEO, Henrik Olsen +46 76 349 7364 

For further information contact:

Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Henrik Olsen +46 76 349 7364

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market patented, needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has 20 employees. Vigmed’s share is traded on NASDAQ OMX First North Premier in Stockholm (ticker VIG) and has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor

Tags: